Shockwave Medical, Inc.
Clinical trials sponsored by Shockwave Medical, Inc., explained in plain language.
A medical device company specializing in intravascular lithotripsy for treating calcified cardiovascular disease.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device SWM-831 tackles hardened leg arteries in japanese study Results expected Jan 2027 (estimated)
- Implantable device could offer new hope for patients with untreatable chest pain Results expected Jul 2027 (estimated)